Compound offers a potential tool for fighting drug-resistant malaria parasites.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.

Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.

Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Heart failure affects 26 million people worldwide. Half die within five years of diagnosis. There's been a lack of progress in finding more effective medications. Advances in understanding mean new options for patients and caregivers.

Hundreds of millions of people worldwide await treatments for rare diseases.